Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2010

Dec 3, 2010

32566_dirs_2010-12-03_8ec3a278-fffc-40e4-97d1-8a43ae497abd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2010-12-03

Reporting Person: GILBERT WALTER PHD (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-12-03 Non-Qualified Stock Option (right to buy) $21.66 A 30000 Acquired 2020-12-03 Common Stock (30000) Direct